BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30551505)

  • 1. Zerumbone inhibits migration in ESCC via promoting Rac1 ubiquitination.
    Wang M; Niu J; Gao L; Gao Y; Gao S
    Biomed Pharmacother; 2019 Jan; 109():2447-2455. PubMed ID: 30551505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.
    Dehghan R; Najafi R; Azizi Jalilian F; Saidijam M; Radaei Z; Zamani A; Ezati R; Asna-Ashari F; Amini R
    Mol Biol Rep; 2021 Jan; 48(1):203-218. PubMed ID: 33398678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro.
    Manandhar B; Paudel KR; Clarence DD; De Rubis G; Madheswaran T; Panneerselvam J; Zacconi FC; Williams KA; Pont LG; Warkiani ME; MacLoughlin R; Oliver BG; Gupta G; Singh SK; Chellappan DK; Hansbro PM; Dua K
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):343-356. PubMed ID: 37439806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells.
    Han J; Bae SY; Oh SJ; Lee J; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Nam SJ; Kim S; Lee JE
    Phytother Res; 2014 Nov; 28(11):1654-60. PubMed ID: 24890258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
    E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zerumbone Exhibits Antiphotoaging and Dermatoprotective Properties in Ultraviolet A-Irradiated Human Skin Fibroblast Cells via the Activation of Nrf2/ARE Defensive Pathway.
    Hseu YC; Chang CT; Gowrisankar YV; Chen XZ; Lin HC; Yen HR; Yang HL
    Oxid Med Cell Longev; 2019; 2019():4098674. PubMed ID: 31814875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2.
    Jegannathan SD; Arul S; Dayalan H
    Nutr Cancer; 2016 Jul; 68(5):865-72. PubMed ID: 27045964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
    Sehrawat A; Sakao K; Singh SV
    Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zerumbone Suppresses Human Colorectal Cancer Invasion and Metastasis via Modulation of FAk/PI3k/NFκB-uPA Pathway.
    Hosseini N; Khoshnazar A; Saidijam M; Azizi Jalilian F; Najafi R; Mahdavinezhad A; Ezati R; Sotanian A; Amini R
    Nutr Cancer; 2019; 71(1):159-171. PubMed ID: 30650987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways.
    Haque MA; Jantan I; Harikrishnan H
    Int Immunopharmacol; 2018 Feb; 55():312-322. PubMed ID: 29310107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
    Zhang Y; Peng X; Zheng Q
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1074-1079. PubMed ID: 29777701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zerumbone inhibits melanoma cell proliferation and migration by altering mitochondrial functions.
    Yan H; Ren MY; Wang ZX; Feng SJ; Li S; Cheng Y; Hu CX; Gao SQ; Zhang GQ
    Oncol Lett; 2017 Apr; 13(4):2397-2402. PubMed ID: 28454410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumbone.
    de Oliveira Silva N; de Lima LVA; de Oliveira LM; da Silva MF; de Aguiar AP; Semprebon SC; Favaron PO; Lepri SR; Felicidade I; Mantovani MS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1561-1573. PubMed ID: 37672080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
    Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
    Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
    Kim JW; Jeong H; Yang MS; Lim CW; Kim B
    Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic effect of Zerumbone on melanoma cells through mitochondria-mediated pathways.
    Wang SD; Wang ZH; Yan HQ; Ren MY; Gao SQ; Zhang GQ
    Clin Exp Dermatol; 2016 Dec; 41(8):858-863. PubMed ID: 27759171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
    Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
    Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.